Cargando…
A Novel M2e Based Flu Vaccine Formulation for Dogs
BACKGROUND: The USA 2004 influenza virus outbreak H3N8 in dogs heralded the emergence of a new disease in this species. A new inactivated H3N8 vaccine was developed to control the spread of the disease but, as in humans and swine, it is anticipated that the virus will mutate shift and drift in the d...
Autores principales: | Leclerc, Denis, Rivest, Marie, Babin, Cindy, López-Macias, Constantino, Savard, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3788766/ https://www.ncbi.nlm.nih.gov/pubmed/24098576 http://dx.doi.org/10.1371/journal.pone.0077084 |
Ejemplares similares
-
Influence of PapMV nanoparticles on the kinetics of the antibody response to flu vaccine
por: Rioux, Gervais, et al.
Publicado: (2016) -
PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccine
por: Rioux, Gervais, et al.
Publicado: (2014) -
Improvement of the Trivalent Inactivated Flu Vaccine Using PapMV Nanoparticles
por: Savard, Christian, et al.
Publicado: (2011) -
Engineering of papaya mosaic virus (PapMV) nanoparticles with a CTL epitope derived from influenza NP
por: Babin, Cindy, et al.
Publicado: (2013) -
Engineering of Papaya Mosaic Virus (PapMV) Nanoparticles through Fusion of the HA11 Peptide to Several Putative Surface-Exposed Sites
por: Rioux, Gervais, et al.
Publicado: (2012)